Compare OCSL & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCSL | ICUCW |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | 18 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | N/A |
| IPO Year | 2008 | 2021 |
| Metric | OCSL | ICUCW |
|---|---|---|
| Price | $12.56 | $0.01 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 962.6K | N/A |
| Earning Date | 02-04-2026 | N/A |
| Dividend Yield | ★ 12.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $316,801,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.38 | N/A |
| P/E Ratio | $32.41 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.44 | N/A |
| 52 Week High | $16.29 | N/A |
| Indicator | OCSL | ICUCW |
|---|---|---|
| Relative Strength Index (RSI) | 33.58 | 56.74 |
| Support Level | $12.64 | $0.01 |
| Resistance Level | $12.98 | $0.05 |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 2.17 | 20.22 |
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.